GP-Act III Acquisition Corp. (NASDAQ:GPAT) Short Interest Update

GP-Act III Acquisition Corp. (NASDAQ:GPAT – Get Free Report) was the recipient of a large growth in short interest during the month of June. As of June 15th, there was short interest totaling 3,999 shares, a growth of 458.5% from the May 31st total of 716 shares. Based on an average daily volume of 4,423 shares, the days-to-cover ratio is currently 0.9 days.

GP-Act III Acquisition Stock Up 1.6%

NASDAQ GPAT traded up $0.17 during trading hours on Friday, hitting $11.05. The company had a trading volume of 300 shares, compared to its average volume of 143,476. GP-Act III Acquisition has a fifty-two week low of $10.50 and a fifty-two week high of $12.00. The firm’s 50 day moving average is $10.88 and its 200 day moving average is $10.80.

Get GP-Act III Acquisition alerts:

GP-Act III Acquisition (NASDAQ:GPAT – Get Free Report) last released its quarterly earnings results on Thursday, May 14th. The company reported $0.06 earnings per share for the quarter.

Hedge Funds Weigh In On GP-Act III Acquisition

Several institutional investors and hedge funds have recently made changes to their positions in GPAT. Longfellow Investment Management Co. LLC acquired a new stake in shares of GP-Act III Acquisition during the third quarter worth approximately $83,000. Bank of America Corp DE acquired a new stake in shares of GP-Act III Acquisition in the 3rd quarter worth about $85,000. Clear Street Group Inc. bought a new stake in shares of GP-Act III Acquisition during the third quarter valued at approximately $109,000. Cannon Global Investment Management LLC boosted its position in GP-Act III Acquisition by 38.1% during the 4th quarter. Cannon Global Investment Management LLC now owns 14,500 shares of the company’s stock worth $155,000 after acquiring an additional 4,000 shares during the period. Finally, Schonfeld Strategic Advisors LLC acquired a new stake in GP-Act III Acquisition in the third quarter worth about $203,000.

Analysts Set New Price Targets

Separately, Weiss Ratings reissued a “sell (d)” rating on shares of GP-Act III Acquisition in a research note on Tuesday, April 21st. One investment analyst has rated the stock with a Sell rating, According to MarketBeat.com, the company has a consensus rating of “Sell”.

Read Our Latest Analysis on GP-Act III Acquisition

GP-Act III Acquisition Company Profile

(Get Free Report)

GP-Act III Acquisition Corp is a special purpose acquisition company organized as a Delaware corporation that completed its initial public offering in 2021. As a blank-check company, it has no commercial operations of its own and was formed to effect a merger, capital stock exchange, asset acquisition, stock purchase, reorganization or similar business combination with one or more businesses.

The company’s primary business activity is to identify and acquire a target company in sectors such as technology, business services, healthcare or other high-growth industries.

Featured Articles

• Five stocks we like better than GP-Act III Acquisition
• Rocket Lab’s NASA Win Tests Key Support After Sharp Pullback
• AST SpaceMobile Just Nailed a Major Launch—So Why Is the Stock Crashing?
• Palantir’s Valuation Problem Just Met 2 New Growth Catalysts
• Xcel Energy Stock Offers Stability as Electricity Demand Builds

Receive News & Ratings for GP-Act III Acquisition Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for GP-Act III Acquisition and related companies with MarketBeat.com's FREE daily email newsletter.